Discovery of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer's disease.
Du Y, Bradshaw WJ, Leisner TM, Annor-Gyamfi JK, Qian K, Bashore FM, Sikdar A, Nwogbo FO, Ivanov AA, Frye SV, Gileadi O, Brennan PE, Levey AI, Axtman AD, Pearce KH, Fu H, Katis VL
J Biol Chem. 2023 Oct 20:105382. doi: 10.1016/j.jbc.2023.105382. PubMed Article
Du Y, Bradshaw WJ, Leisner TM, Annor-Gyamfi JK, Qian K, Bashore FM, Sikdar A, Nwogbo FO, Ivanov AA, Frye SV, Gileadi O, Brennan PE, Levey AI, Axtman AD, Pearce KH, Fu H, Katis VL
J Biol Chem. 2023 Oct 20:105382. doi: 10.1016/j.jbc.2023.105382. PubMed Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 211823 | pDEST27-GST-hMSN | Express human MSN in mammalian cells |
| 211824 | pFUW-VenusFlag-hCD44 | Express CD44 in mammalian cells |